Trial intelligence / Profile preview

Accelerated Hepatitis B Vaccination in Hemodialysis Patients

NCT03149874Completed

Sponsor
Benha University
Start
Dec 2014
Primary completion
Apr 2017
Modality
Vaccines & Immunotherapeutics
01

Overview

Randomised, open-label trial of hepatitis b vaccine recombinant in hepatitis B (HBV) (2 arms), sponsored by Benha University. Primary endpoints: Hepatitis B virus Seroprotection after one month and Hepatitis B virus Seroprotection after three months. Started Dec 2014; status: completed.

02

Drugs

hepatitis b vaccine recombinant
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on NCT03149874.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03149874.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call